Canaccord Genuity Starts Pernix Therapeutics (PTX) at Buy; Robust Growth with Business Fevelopment to Further Fuel P&L Upside
Tweet
Share
E-mailGet Alerts PTX Hot Sheet
Price: $0.21 --0%
Rating Summary:
4 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - Canaccord Genuity initiates coverage on Pernix Therapeutics (NYSE: PTX) with a Buy. PT $15.00.
Canaccord analyst, Randall Stanicky, said, "We see in a Pernix a low-risk sales and marketing platform with an active business development effort that can continue to fund robust top-line growth. Strong balance sheet and expanding therapeutic interest collectively cast a broad net around potential opportunities with recent success in pediatrics providing support to track record. Our three-year revenue CAGR projection of 32% supports
a 45% EPS growth rate estimate that has further upside potential from both JV activity and anticipated business development not in our model."
To see more ratings on PTX, Click Here
Canaccord analyst, Randall Stanicky, said, "We see in a Pernix a low-risk sales and marketing platform with an active business development effort that can continue to fund robust top-line growth. Strong balance sheet and expanding therapeutic interest collectively cast a broad net around potential opportunities with recent success in pediatrics providing support to track record. Our three-year revenue CAGR projection of 32% supports
a 45% EPS growth rate estimate that has further upside potential from both JV activity and anticipated business development not in our model."
To see more ratings on PTX, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Starts Everus (ECG) at Buy
- Keefe, Bruyette & Woods Resumes Canadian Imperial Bank of Commerce (CM:CN) (CM) at Market Perform
- William Blair Starts Beta Bionics, Inc. (BBNX) at Market Perform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
